MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-20-0014474
Xena Formulations Private Limited
Xena Formulations Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.74 Lakh
Latest filing
Net loss · FY 2025
₹37,687
Net margin -2.3%
EBITDA · FY 2025
-₹37,687
EBITDA margin -2.3%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Xena Formulations Private Limited
Data last updated:
Xena Formulations Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2019PTC050369. Its GSTIN is 23AAACX3143L2ZD (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Bipin Kumar Pandey and Ritesh Sohgaura.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 151 Swami Dayanand Nagar, Indore, Madhya Pradesh, India – 452009.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.74 Lakh. For the same year it recorded a net loss of ₹37,687 (net margin -2.3%) and EBITDA of -₹37,687 (EBITDA margin -2.3%).
Xena Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-20-0014474).
Company Details of Xena Formulations Private Limited
CIN U24230MP2019PTC050369
Registration Number 050369
Incorporation Date 16 December 2019
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-20-0014474
Recognitions & Rankings of Xena Formulations
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address151 Swami Dayanand Nagar, Indore, Madhya Pradesh, India – 452009
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Xena Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Xena Formulations Private Limited FY 2025 filings available
Xena Formulations Private Limited reported revenue of ₹16.74 Lakh for FY 2025.
Revenue · FY 2025
₹16.74 Lakh
Net loss · FY 2025
₹37,687 margin -2.3%
EBITDA · FY 2025
-₹37,687 margin -2.3%
Financial Statement Summary of Xena Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹37,687 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹37,687 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Xena Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Xena Formulations are in the company report.
Premium access
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Xena Formulations Private Limited
Xena Formulations has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bipin Kumar Pandey Also directs: Xena Coronus Health Care Private Limited | Director | 16 Dec 2019 | 6 Years 10 Months | Current |
| Ritesh Sohgaura Also directs: Xena Coronus Health Care Private Limited | Director | 16 Dec 2019 | 6 Years 10 Months | Current |
Peer Comparison of Xena Formulations Private Limited
Xena Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Super Pneumatics Pvt Ltd | ₹16.98 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Ninai Life Sciences Private Limited | ₹16.87 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Panvel, Maharashtra, India |
| Celestial Biolabs Limited Listed | ₹16.87 Lakh (FY 2023) | •••• | •••• | 14.0% | •••• | Hyderabad, Telangana, India |
| Med-Interplast (India) Private Limited | ₹16.79 Lakh (FY 2022) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Oyster Pharma Pvt Ltd | ₹16.77 Lakh (FY 2025) | •••• | •••• | -68.0% | •••• | Solan, Himachal Pradesh, India |
| Xena Formulations Private Limited this company | ₹16.74 Lakh (FY 2025) | •••• | •••• | •••• | Indore, Madhya Pradesh, India | |
| Kumra Pharma Private Limited | ₹16.73 Lakh (FY 2024) | •••• | •••• | 321.0% | •••• | Delhi, India |
| Agrawal Medicaments Private Limited | ₹16.64 Lakh (FY 2024) | •••• | •••• | -28.0% | •••• | Margao, Goa, India |
| Navkar Formulation Pvt Ltd | ₹16.64 Lakh (FY 2019) | •••• | •••• | 1.0% | •••• | Ahmedabad, Gujarat, India |
| Chembricks Laboratories Private Limited | ₹16.58 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Napsko Healthcare Private Limited | ₹16.56 Lakh (FY 2024) | •••• | •••• | -46.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Xena Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Xena Formulations Private Limited
Xena Formulations Private Limited is audited by SPJV&CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SPJV&CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Xena Formulations Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Xena Formulations Private Limited
Xena Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Xena Formulations Private Limited
Employment history and EPFO contributions of people linked to Xena Formulations.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Xena Formulations Private Limited
Xena Formulations Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Bipin Kumar Pandey was appointed as Director on 16 Dec 2019.
AGM
Xena Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Xena Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Bipin Kumar Pandey was appointed as Director.
Appointed
Ritesh Sohgaura was appointed as Director.
Incorporation
16 Dec 2019
Xena Formulations Private Limited was registered on 16 Dec 2019 with Roc Gwalior & aged 6 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Xena Formulations Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Xena Formulations Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Xena Formulations Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Xena Formulations Private Limited
Xena Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACX3143L2ZD | Madhya Pradesh | Active | 28 Jan 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Xena Formulations Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xena Formulations Private Limited
Xena Formulations is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 December 2019 (7+ years old) and is registered under CIN U24230MP2019PTC050369.
Xena Formulations reported revenue of ₹16.74 Lakh for FY 2025.
Xena Formulations has 2 current directors:
- Bipin Kumar Pandey - Director
- Ritesh Sohgaura - Director
Xena Formulations reported a net loss of ₹37,687 (net margin -2.3%) and EBITDA of -₹37,687 (EBITDA margin -2.3%) for FY 2025, as per its filed financial statements.
The GSTIN of Xena Formulations is 23AAACX3143L2ZD, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Xena Formulations is U24230MP2019PTC050369. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xena Formulations was incorporated on 16 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Xena Formulations by revenue are Super Pneumatics Pvt Ltd, Ninai Life Sciences Private Limited, Celestial Biolabs Limited, Med-Interplast (India) Private Limited, Oyster Pharma Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Bipin Kumar Pandey was appointed as Director on 16 Dec 2019. Ritesh Sohgaura was appointed as Director on 16 Dec 2019.
Yes, Xena Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-20-0014474).
The registered office of Xena Formulations is at 151 Swami Dayanand Nagar, Indore, Madhya Pradesh, India – 452009.